0000-0001-5738-6299 Employment
-
College of Pharmaceutical Sciences Professor2008 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (12)
- Pharmacophore Based Design of Probable FGFR-1 Inhibitors from the 3D Crystal Structure of Infigratinib - A Drug Used in the Treatment of Cholangiocarcinomas Save
- In silico Enhancement of VEGFR-2 Binding Properties of 5- Amino-2-(3,4-Dimethoxyphenylsulfonamido)-5-Oxopentanoic Acid (SM-1) for Improving its Anticancer Activity Save
- Identification, Biological Evaluation & Retrometabolic Drug Designing of Active Metabolites of 5-Amino-2-(3, 4-Dimethoxy Phenyl Sulfonamido)-5-Oxopentanoic Acid (SM-1) As Antimultiple Myeloma and Antiangiogenic Agents Save
- RATIONAL DESIGN, SYNTHESIS AND IN VITRO EVALUATION OF N-(4-ETHOXYPHENYLSULFONYL)-L-GLUTAMIC ACID ANALOGUES AS ANTIANGIOGENIC AND ANTICANCER AGENTS ON MULTIPLE MYELOMA Save
- Design, synthesis and in vitro evaluation of 2-(quinoline-8-sulfonamido)pentanedioic acid analogues as antiangiogenic and antitumor agents on multiple myeloma Save
- Design, synthesis, molecular docking and in vitro evaluation of n -(4-ethoxyphenylsulfonyl)pyrrolidine-2-carboxylic acid analogues as antiangiogenic and anticancer agents on multiple myeloma Save
- Design, synthesis, molecular docking and in vitro evaluation of N-(4-methoxyphenylsulfonyl)pyrrolidine-2-carboxylic acid analogues as antiangiogenic and anticancer agents on multiple myeloma Save
- Transmuting methotrexate in to a potential binder of dihydrofolate reductase Save
- Possible antineoplastic agents, part XVII: Synthesis, antitumor and antiangiogenic study of few bioisosteres of thalidomide metabolites Save
- A validated stability indicating RP-HPLC method for the determination of rimonabant in bulk and pharmaceutical dosage forms Save